AMES Technology Inc., has developed and is bringing to market a new technology which it believes to be the most significant breakthrough to occur in stroke therapy in the last 25 years.  This non-invasive, patented technology has been shown in pre-clinical trials to significantly increase mobility, manipulative skills, and everyday functionality in highly disabled chronic stroke patients.

AMES Technology Inc. is currently conducting sub-acute clinical trials in locations around the U.S.

This is an investigational device limited by Federal law to investigational use only.